To confirm the therapeutic effect of HDAC6 inhibition, we treated the CG-induced peritoneal fibrosis mouse model with TA and found a significant alleviation of fibrosis and reduced extracellular matrix protein deposition. The gene discussed is HDAC6; the disease is Peritoneal Fibrosis.